Sample | Title | Value | Rank |
GSM1256958 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 2 | 358.383 | 90 |
GSM1256959 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 4 | 902.275 | 96 |
GSM1256960 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 7 | 52.2546 | 68 |
GSM1256961 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 8 | 158.416 | 82 |
GSM1256962 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 9 | 186.744 | 83 |
GSM1256963 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 12 | 116.575 | 78 |
GSM1256972 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 54 before YFV | 61.5021 | 69 |
GSM1256976 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 54 seven days after YFV | 30.8058 | 61 |
GSM1256973 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 55 before YFV | 39.242 | 62 |
GSM1256977 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 55 seven days after YFV | 37.41 | 61 |
GSM1256974 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 56 before YFV | 59.6179 | 67 |
GSM1256978 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 56 seven days after YFV | 48.1605 | 65 |
GSM1256975 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 57 before YFV | 24.3351 | 54 |
GSM1256979 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 57 seven days after YFV | 29.6494 | 58 |